Valentina Tateo - Search Results

Year	Number of Results
2020	1
2021	2
2023	14
2024	5

1

An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma.

Rosellini M, Tassinari E, Marchetti A, Tateo V, Nuvola G, Rizzo A, Massari F, Mollica V. Rosellini M, et al. Among authors: tateo v. Expert Opin Drug Saf. 2023 Apr;22(4):279-291. doi: 10.1080/14740338.2023.2203486. Epub 2023 Apr 16. Expert Opin Drug Saf. 2023. PMID: 37055875 Review.

2

Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics.

Tateo V, Marchese PV, Mollica V, Massari F, Kurzrock R, Adashek JJ. Tateo V, et al. Pharmaceuticals (Basel). 2023 Apr 19;16(4):614. doi: 10.3390/ph16040614. Pharmaceuticals (Basel). 2023. PMID: 37111371 Free PMC article. Review.

3

Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.

Ricci C, Ambrosi F, Franceschini T, Giunchi F, Grillini A, Franchini E, Grillini M, Schiavina R, Massari F, Mollica V, Tateo V, Bianchi FM, Bianchi L, Droghetti M, Maloberti T, Tallini G, Colecchia M, Acosta AM, Lobo J, Trpkov K, Fiorentino M, de Biase D. Ricci C, et al. Among authors: tateo v. Virchows Arch. 2023 Nov;483(5):687-698. doi: 10.1007/s00428-023-03673-9. Epub 2023 Oct 17. Virchows Arch. 2023. PMID: 37845471 Free PMC article. Review.

4

Hacking Pancreatic Cancer: Present and Future of Personalized Medicine.

Di Federico A, Tateo V, Parisi C, Formica F, Carloni R, Frega G, Rizzo A, Ricci D, Di Marco M, Palloni A, Brandi G. Di Federico A, et al. Among authors: tateo v. Pharmaceuticals (Basel). 2021 Jul 15;14(7):677. doi: 10.3390/ph14070677. Pharmaceuticals (Basel). 2021. PMID: 34358103 Free PMC article. Review.

5

First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis.

Mosca M, Conci N, Di Federico A, Tateo V, Favorito V, Zappi A, Gelsomino F, De Giglio A. Mosca M, et al. Among authors: tateo v. JCO Precis Oncol. 2023 May;7:e2300073. doi: 10.1200/PO.23.00073. JCO Precis Oncol. 2023. PMID: 37262392 Review.

6

Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.

Tateo V, Manuzzi L, De Giglio A, Parisi C, Lamberti G, Campana D, Pantaleo MA. Tateo V, et al. Int J Mol Sci. 2020 Nov 28;21(23):9056. doi: 10.3390/ijms21239056. Int J Mol Sci. 2020. PMID: 33260538 Free PMC article. Review.

7

Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study.

Rizzo A, Mollica V, Tateo V, Tassinari E, Marchetti A, Rosellini M, De Luca R, Santoni M, Massari F. Rizzo A, et al. Among authors: tateo v. Cancer Immunol Immunother. 2023 Jun;72(6):1381-1394. doi: 10.1007/s00262-023-03366-x. Epub 2023 Jan 25. Cancer Immunol Immunother. 2023. PMID: 36695827 Free PMC article. Review.

8

An Overview on Molecular Characterization of Thymic Tumors: Old and New Targets for Clinical Advances.

Tateo V, Manuzzi L, Parisi C, De Giglio A, Campana D, Pantaleo MA, Lamberti G. Tateo V, et al. Pharmaceuticals (Basel). 2021 Apr 1;14(4):316. doi: 10.3390/ph14040316. Pharmaceuticals (Basel). 2021. PMID: 33915954 Free PMC article. Review.

9

How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?

Conci N, Tassinari E, Tateo V, Rosellini M, Marchetti A, Ricci C, Chessa F, Santoni M, Grande E, Mollica V, Massari F. Conci N, et al. Among authors: tateo v. Mol Diagn Ther. 2024 Jan;28(1):37-51. doi: 10.1007/s40291-023-00679-6. Epub 2023 Oct 24. Mol Diagn Ther. 2024. PMID: 37874465 Review.

10

Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer.

Necchi A, Basile G, Gibb EA, Raggi D, Calareso G, de Padua TC, Patanè D, Crupi E, Mercinelli C, Cigliola A, Tateo V, Giannatempo P, Moschini M, Briganti A, Montorsi F, Messina A, Ross JS, Pavlick D, De Cobelli F, Brembilla G. Necchi A, et al. Among authors: tateo v. BJU Int. 2024 Feb;133(2):214-222. doi: 10.1111/bju.16191. Epub 2023 Oct 16. BJU Int. 2024. PMID: 37803523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year